Features

Most Recent

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By The Scientist Staff | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Targeting DNA

Targeting DNA

By Jef Akst | June 1, 2012

After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.

13 Comments

image: Underground Supermodels

Underground Supermodels

By Thomas J. Park and Rochelle Buffenstein | June 1, 2012

What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?

12 Comments

Data Diving

By Kerry Grens | May 1, 2012

What lies untapped beneath the surface of published clinical trial analyses could rock the world of independent review.

28 Comments

image: Freezing Time

Freezing Time

By Vern L. Schramm | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: Telomeres in Disease

Telomeres in Disease

By Rodrigo Calado and Neal Young | May 1, 2012

Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.

16 Comments

image: Best Places to Work Postdocs, 2012

Best Places to Work Postdocs, 2012

By Sabrina Richards | April 2, 2012

Much has changed in the last 10 years for postdocs, who are staying in their positions longer than ever before—and coming out with more to show for it.

0 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By Suling Liu, Hasan Korkaya, and Max S. Wicha | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

Deliberating Over Danger

By The Scientist Staff | April 1, 2012

The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.

16 Comments

image: What it Takes to Develop Better Drugs for Kids

What it Takes to Develop Better Drugs for Kids

By J. Steven Leeder | March 1, 2012

Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials.  

2 Comments

Popular Now

  1. Stem Cell Vaccine Protects Mice From Cancer
  2. Love in the Scientific Literature
    News Analysis Love in the Scientific Literature

    There are countless ways for scientists to say, “I love you.” Naming a slime-mold beetle after your wife (and another after your ex-wife) is, apparently, one of them.  

  3. DNA Robots Target Cancer
    Daily News DNA Robots Target Cancer

    Researchers use DNA origami to generate tiny mechanical devices that deliver a drug that cuts off the blood supply to tumors in mice.

  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS